Christine Jenkins's Publications

About Christine Jenkins's Publications

Program Head, Respiratory
  • Professor of Respiratory Medicine, Faculty of Medicine, UNSW Sydney
  • Clinical Professor, Concord Clinical School, University of Sydney
  • AM,
  • MD,
  • FRACP,
  • FThor ,
  • Soc ,
  • FAAHMS

  • Clinical Decision Support System for Breathlessness

    Current Opinion in Supportive & Palliative Care Date published:

  • The modified in Manila Medical Research Council dyspnoea scale

    The Lancet Respiratory Medicine Date published:

  • The use of precision medicine for asthma

    Frontiers in Medicine Date published:

  • A Bayesian network for identifying causes of breathlessness using a national electronic medical records (EMR) database

    Scientific Reports Date published:

  • Personalising the management of obesity-related asthma using medical nutrition therapy and physical activity prescription: The IDEAL study protocol

    Contemporary Clinical Trials Date published:

  • Bisoprolol to prevent adverse cardiac events (PACE) in COPD: a multicentre, double-blind, randomised, controlled, phase 3 trial

    The Lancet Respiratory Medicine Date published:

  • Derivation and Definitions of Clinical Study Variables for Multiple Long Term Conditions in Patients with Chronic Obstructive Pulmonary Disease: Protocol for a Modified Delphi Methods and Consensus Study on Behalf of the International Cardiovascular and Respiratory Alliance

    Pragmatic and Observational Research Date published:

  • Digital support for chronic dyspnoea management in primary care: protocol for the BREATHE (Breathlessness Rapid Evaluation and Therapy) cluster randomised controlled trial

    BMJ Open Date published:

  • CURE Asthma: a unique opportunity for Australia

    Medical Journal of Australia Date published:

  • The CURE Asthma roadmap

    Medical Journal of Australia Date published:

  • Mepolizumab treatment and reduced oral corticosteroid exposure improves symptoms of depression and anxiety in severe eosinophilic asthma: data from the Australian Mepolizumab Registry

    Respiratory Medicine Date published:

  • Late Breaking Abstract - Bisoprolol to prevent adverse cardiac events (PACE) in COPD: a 2-year RCT

    Airway pharmacology and treatment Date published:

  • Extrafine beclometasone/formoterol is non-inferior to budesonide/formoterol as maintenance and reliever therapy (MART) for adult asthma patients and reduces the total carbon footprint of all inhaler-related greenhouse gas (GHG) emissions.

    Airway pharmacology and treatment Date published:

  • Rebranding COPD Care and Research in the 21st Century

    Respirology Date published:

  • Pre-COPD: an evolving concept with practice potential

    The Lancet Respiratory Medicine Date published:

  • Scanning the respiratory service landscape in NSW-based Aboriginal Community Controlled Health Services

    BMC Health Services Research Date published: